ANTIFUNGAL TREATMENT

This adverse event was reported 8 times

These drugs are most commonly taken by patients reporting ANTIFUNGAL TREATMENT:

# Drug Count
0 BLINATUMOMAB 1
1 CANDESARTAN 1
2 CYTARABINE 1
3 DAPAGLIFLOZIN 1
4 FINASTERIDE 1
5 IVOSIDENIB 1
6 IXEKIZUMAB 1
7 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1
8 REVUMENIB 1
9 SECUKINUMAB 1
See all common drugs associated with ANTIFUNGAL TREATMENT

ANTIFUNGAL TREATMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 REVUMENIB 1 0.0010
1 IVOSIDENIB 1 0.0005
2 BLINATUMOMAB 1 0.0001
3 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 1 0.0001
4 CANDESARTAN 1 0.0000
5 IXEKIZUMAB 1 0.0000
6 SUNITINIB MALATE 1 0.0000
7 DAPAGLIFLOZIN 1 0.0000
8 CYTARABINE 1 0.0000
9 FINASTERIDE 1 0.0000
See all drugs enriched for association with ANTIFUNGAL TREATMENT

ANTIFUNGAL TREATMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Isocitrate Dehydrogenase 1 Inhibitor [EPC] 1 0.0005
1 Interleukin-17A Antagonist [EPC] 1 0.0000
2 5-alpha Reductase Inhibitor [EPC] 1 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with ANTIFUNGAL TREATMENT